Related references
Note: Only part of the references are listed.A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer
Diptee A. Kulkarni et al.
CARCINOGENESIS (2009)
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis
V. Marcel et al.
JOURNAL OF MEDICAL GENETICS (2009)
Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia
Xiujuan Xiong et al.
LEUKEMIA RESEARCH (2009)
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene
Gurinder Singh Atwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers
Xingming Chen et al.
CARCINOGENESIS (2008)
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
J-C Marine et al.
CELL DEATH AND DIFFERENTIATION (2006)
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2006)
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Gareth L. Bond et al.
CANCER RESEARCH (2006)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Germline TP53 mutations in breast cancer families with multiple primary cancers:: is TP53 a modifier of BRCA1? -: art. no. e34
AM Martin et al.
JOURNAL OF MEDICAL GENETICS (2003)
Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk
SJ Hwang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
P Dumont et al.
NATURE GENETICS (2003)
Share Paper
